LON:SBI

Sourcebio International (SBI) Share Price, News & Analysis

GBX 115
+5.00 (+4.55%)
(As of 12/29/2022)
Today's Range
105
125
50-Day Range
115
115
52-Week Range
90
170
Volume
1.57 million shs
Average Volume
152,444 shs
Market Capitalization
£85.31 million
P/E Ratio
1,277.78
Dividend Yield
N/A
Price Target
N/A
SBI stock logo

About Sourcebio International Stock (LON:SBI)

Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company's services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services. It also manufactures library clones, direct to consumer home test kits, and blood and tissue serological products; and provides employee testing solutions and venue testing. In addition, the company offers controlled environment storage services and diagnostic and genomic services and products. Sourcebio International Plc was founded in 1999 and is headquartered in Nottingham, the United Kingdom.

SBI Stock Price History

SBI Stock News Headlines

Sourcebio International (LON:SBI) Shares Up 4.5%
“Retirement Secret” Showed 995% Gain Last Time We Shared It
Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.
Sourcebio International Plc (SBI.L)
“Retirement Secret” Showed 995% Gain Last Time We Shared It
Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.
See More Headlines
Receive SBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sourcebio International and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Care Facilities
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
194
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£75.61 million
Cash Flow
GBX 21.32 per share
Book Value
GBX 61.90 per share

Miscellaneous

Free Float
N/A
Market Cap
£85.31 million
Optionable
Not Optionable
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Jay Charles LeCoque (Age 59)
    Exec. Chairman
  • Mr. Anthony James Ratcliffe ACA (Age 58)
    BSc, MBA, CFO, Company Sec. & Exec. Director
  • Mr. Russell Wheatcroft
    Chief Operating Officer

SBI Stock Analysis - Frequently Asked Questions

How have SBI shares performed in 2024?

Sourcebio International's stock was trading at GBX 115 at the beginning of the year. Since then, SBI shares have increased by 0.0% and is now trading at GBX 115.
View the best growth stocks for 2024 here
.

How do I buy shares of Sourcebio International?

Shares of SBI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:SBI) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners